The making of a killer (T cell)

por Overwijk, Willem W.
Publicado 2017

Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyard

por Hailemichael, Yared, Overwijk, Willem W
Publicado 2013

Adjuvants for peptide-based cancer vaccines

por Khong, Hiep, Overwijk, Willem W.
Publicado 2016

Reversing gp100/IFA-induced impairment of anti-CTLA-4 checkpoint blockade therapy

por Hailemichael, Yared, Fu, Tihui, Khong, Hiep, Dai, Zhimin, Sharma, Padmanee, Overwijk, Willem W
Publicado 2014

Soluble Interleukin-15 Complexes Are Generated In Vivo by Type I Interferon Dependent and Independent Pathways

por Anthony, Scott M., Howard, Megan E., Hailemichael, Yared, Overwijk, Willem W., Schluns, Kimberly S.
Publicado 2015

The immune system in cancer metastasis: friend or foe?

por Janssen, Louise M.E., Ramsay, Emma E., Logsdon, Craig D., Overwijk, Willem W.
Publicado 2017

Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors

por Overwijk, Willem W, Wang, Ena, Marincola, Francesco M, Rammensee, Hans-Georg, Restifo, Nicholas P
Publicado 2013

Characterization of the Inflammatory Microenvironment and Identification of Potential Therapeutic Targets in Wilms Tumors()()

por Maturu, Paramahamsa, Overwijk, Willem W., Hicks, John, Ekmekcioglu, Suhendan, Grimm, Elizabeth A., Huff, Vicki
Publicado 2014

Induction of systemic anti-melanoma immunity through intratumoral TLR-7/8 activation

por Singh, Manisha, Khong, Hiep, Dai, Zhimin, Vasilakos, John P, Hwu, Patrick, Overwijk, Willem W
Publicado 2014

Immune cell profiling in cancer: molecular approaches to cell-specific identification

por Lyons, Yasmin A., Wu, Sherry Y., Overwijk, Willem W., Baggerly, Keith A., Sood, Anil K.
Publicado 2017

Role of Cyclooxygenase-2 Pathway in Creating an Immunosuppressive Microenvironment and in Initiation and Progression of Wilms' Tumor

por Maturu, Paramahamsa, Jones, Devin, Ruteshouser, E. Cristy, Hu, Qianghua, Reynolds, Joseph M, Hicks, John, Putluri, Nagireddy, Ekmekcioglu, Suhendan, Grimm, Elizabeth A., Dong, Chen, Overwijk, Willem W
Publicado 2017

Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen: Implications for Tumor Immunotherapy

por Colella, Teresa A., Bullock, Timothy N.J., Russell, Liane B., Mullins, David W., Overwijk, Willem W., Luckey, Chance John, Pierce, Richard A., Restifo, Nicholas P., Engelhard, Victor H.
Publicado 2000

gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand

por Overwijk, Willem W., Tsung, Allan, Irvine, Kari R., Parkhurst, Maria R., Goletz, Theresa J., Tsung, Kangla, Carroll, Miles W., Liu, Chunlei, Moss, Bernard, Rosenberg, Steven A., Restifo, Nicholas P.
Publicado 1998

Generation of a novel therapeutic peptide that depletes MDSC in tumor-bearing mice

por Qin, Hong, Lerman, Beatrisa, Sakamaki, Ippei, Wei, Guowei, Cha, Soungchul, Rao, Sheetal S., Qian, Jianfei, Hailemichael, Yared, Nurieva, Roza, Dwyer, Karen C., Roth, Johannes, Yi, Qing, Overwijk, Willem W., Kwak, Larry W.
Publicado 2014

Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine: Compariso...

por van Elsas, Andrea, Sutmuller, Roger P.M., Hurwitz, Arthur A., Ziskin, Jennifer, Villasenor, Jennifer, Medema, Jan-Paul, Overwijk, Willem W., Restifo, Nicholas P., Melief, Cornelis J.M., Offringa, Rienk, Allison, James P.
Publicado 2001

Tumor immunology and cancer immunotherapy: summary of the 2014 SITC primer

por Page, David B., Bourla, Ariel Bulua, Daniyan, Anthony, Naidoo, Jarushka, Smith, Eric, Smith, Melody, Friedman, Claire, Khalil, Danny N., Funt, Samuel, Shoushtari, Alexander N., Overwijk, Willem W., Sharma, Padmanee, Callahan, Margaret K.
Publicado 2015

Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule

por Kaufman, Howard L., Butterfield, Lisa H., Coulie, Pierre G., Demaria, Sandra, Ferris, Robert L., Galon, Jérôme, Khleif, Samir N., Mellman, Ira, Ohashi, Pamela S., Overwijk, Willem W., Topalian, Suzanne L., Marincola, Francesco M.
Publicado 2016

B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade

por Singh, Shubhra, Roszik, Jason, Saini, Neeraj, Singh, Vipul Kumar, Bavisi, Karishma, Wang, Zhiqiang, Vien, Long T., Yang, Zixi, Kundu, Suprateek, Davis, Richard E., Bover, Laura, Diab, Adi, Neelapu, Sattva S., Overwijk, Willem W., Rai, Kunal, Singh, Manisha
Publicado 2022

Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15

por Fernandez, Rafael Alonso, Mayoral, Jessica Encinas, Pierre-Louis, Laetitia, Yao, Yao, Xu, Yan, Mu, Shidai, Martinez-Lopez, Joaquin, Primo, Daniel, Miyazaki, Takahiro, Prabhala, Rao, Anderson, Kenneth C., Overwijk, Willem W., Munshi, Nikhil C., Fulciniti, Mariateresa
Publicado 2022

A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy

por Hirayama, Alexandre V., Chou, Cassie K., Miyazaki, Takahiro, Steinmetz, Rachel N., Di, Henna A., Fraessle, Simon P., Gauthier, Jordan, Fiorenza, Salvatore, Hawkins, Reed M., Overwijk, Willem W., Riddell, Stanley R., Marcondes, Mario Q., Turtle, Cameron J.
Publicado 2022